NCT06174454 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

European Respiratory Society Annual Congress
Effects of a new chest physiotherapy protocol in infant RSV bronchiolitis; 4-8 october. Berlín: European Respiratory Society; 2008.
Girardi G, et al
El Programa IRA en Chile: hitos e historia. Chil Ped (Chil). 2001; 72: 292-300.
Postiaux G, Hankard R, Saulnier JP, Karolewicz S, Binielli J, Le Dinahet T
La kinésithérapie dans la bronchiolite du nourrisson: faut-il vraiment abandonner? Arc Ped (Fra). 2014; 21:452-53.

Clinical Efficacy of Respiratory Pediatric Physiotherapy on a Child With Hospital Treated Pneumonia: Single-Blind Clinical Trial

Clinical trial NCT06174454 - References